Importance of Acinetobacter baumannii in the hospital environment
DOI:
https://doi.org/10.20873/jbb.uft.cemaf.v8n1.cangussuKeywords:
health, infectious, mechanical ventilationAbstract
Acinetobacter species are known as important opportunistic pathogens, especially in immunocompromised and hospitalized patients. Frequently the spread of A. baumannii occurs contact between patients, or through health professionals, directly or indirectly. A. baumannii has been the focus of attention of the scientific and medical community. In light of the foregoing, this paper aims to describe, through systematic literature review, about this species, its potegenicity and virulence, as well as to report on its prevalence and incidence. infectious agent in the hospital room. A bibliographic survey was carried out in Portuguese and English periodicals from 2000 to 2019 in the MEDLINE and LILACS databases. 34 bibliographic works were analyzed and inserted. Acinetobacter species have a range of virulence factors that enable survival and adaptation of microorganisms in the environment and resistance acquisition is accomplished by a variety of mechanisms. Immunocompromised and mechanically ventilated patients are commonly colonized and infected with this bacterial species. Based on the literature, it can be seen that A. baumannii has gained prominence and relevance as an infectious agent in the hospital environment. In particular, its role as an etiologic agent in ventilator-associated pneumonia shows how important strategies for prophylactic and preventive methods.
References
ANVISA - Agência Nacional de Vigilância Sanitária. (2010). Medidas para identificação, prevenção e controle de infec-ções relacionadas à assistência à saúde por microrganismos multirresistentes. Brasília.
Chagas TPG. Caracterização de Acinetobacter spp. multirresis-tentes produtores de carbapenemases, dos tipos OXA e NDM, isolados de diferentes regiões do Brasil. 2015. 133p. Tese (Doutorado em Ciências-Medicina Tropical). Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro.
Choi CH, Lee JS, Lee YV, Lee JC. Acinetobacter baumannii invades epithelial cells and outer membrane protein A medi-ates interactions with epithelial cells. BMC Microbiol, v.8, n.1, p.216, 2008.
Chopra S, Galande A. A fluoroquinolone-resistant Acineto-bacter baumannii without the quinolone resistance-determining region mutations. Journal of Antimicrobial Chemotherapy, v.66, n.11, p.2668-2670, 2011. https://doi.org/10.1093/jac/dkr364
Ciello G, Araujo MC. Perfil epidemiológico do Acinetobacter baumannii resistente a carbapenens num hospital do interior mineiro. REFACS (online), v.4, v.3, p.201-207, 2016. https://doi:10.18554/refacs.v4i3.1772
Coelho MJAN. Acinetobacter baumannii uma realidade hospi-talar. 2012. 131 p. Dissertação (Mestrado em Gestão e Eco-nomia da Saúde). Universidade de Coimbra, Coimbra.
Costa JB; Costa AL; Torres F; Silva AFG; Terra Junior AT. Os principais fatores de risco da pneumonia associada à ventilação mecânica em UTI Adulta. Revista Científica da Faculdade de Educação e Meio Ambiente, v. 7, n. 1, p. 80-92, 2016.
Davis KA et al. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis., v.11, p.12-18, 2005.
Dou Y, Song F, Guo F, Zhou Z, Zhu C, Ziang J; Huan J. Acinetobacter baumannii quorum-sensing signalling mole-cule induces the expression of drug-resistance genes. Mol Med Rep, v. 15, n. 6, p. 4061-4068, 2017. https://doi:10.3892/mmr.2017.6528
Duarte AFS. Estudos de susceptibilidade e formação de bio-filmes de várias estirpes de Acinetobacter baumannii. 2011. 92 p. Dissertação (Mestrado em Bioquímica). Universidade da Beira Interior, Covilhã.
El mekes AZK, Ait said L, Ouafi AT, Barakate M. The clinical and epidemiological risk factors of infections due tomulti-drug resistant bacteria in an adult intensive care unit of Uni-versity Hospital Center in Marrakesh-Morocco. Journal of Infection and Public Health. v.19, n.1, p.30292-8, 2019.
https://doi.org/10.1016/j.jiph.2019.08.012
Figueiredo DQ, Castro LF, Santos KRN, Teixeira LM, Mon-dino SSB. Detecção de metalo-beta-lactamases em amostras hospitalares de Pseudomonas aeruginosa e Acinetobacter baumannii. Bras Patol Med Lab, v.45, n.3, p.177-184, 2009.
Gales AC, Jones RN, et al. Global assessment of the antimi-crobial activity of polymyxin B against 54,731 clinical iso-lates of gram-negative bacilli: report from the SENTRY an-timicrobial surveillance programme (2001–2004). Clin Mi-crobiol Infect, v.12, n.1, p.315–321, 2006.
Gusatti CS, Ferreira AE, Fuentefria DB, Corção G. Resistên-cia a β-lactâmicos em Acinetobacter spp. isolados de efluen-te hospitalar no sul do Brasil. Revista da Sociedade Brasilei-ra de Medicina Tropical v.42, n.2, p.183-187, 2009.
Koneman EW. (2008). Diagnóstico microbiológico: texto e atlas colorido. 6.ed. Rio de Janeiro, Medsi.
Luiz SO. Caracterização da resistência de amostras de Acineto-bacter baumannii isoladas no Hospital de Clínicas de Curi-tiba.2006. 89p. Dissertação (Mestrado em Microbiologia, Parasitologia e Patologia). Universidade Federal do Paraná, Curitiba.
Oliveira AC, Damasceno QS. Superfícies do ambiente hospi-talar como possíveis reservatórios de bactérias resistentes: uma revisão. Ver. Esc. Enferm. USP, v.44, n.4, p.1118-23, 2010.
Peleg AY, Adams J, Paterson DL. Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter bau-mannii. Antimicrob. Agents Chemother. v.51, n.1, p.2065–2069, 2008.
Pereira DCR. Caracterização da resistência de isolados clínicos de Acinetobacter baumannii a antimicrobianos e desinfetante hospitalar. 2013. 104 p. Dissertação (Mestrado em Vigilân-cia Sanitária). Fundação Oswaldo Cruz, Rio de Janeiro.
Perez F, Hujer AM, Hujer KM, Decker BK, RATHER PN, Bonomo RA. Global challenge of multidrug-resistant Aci-netobacter baumannii. Antimicrob Agents Chemother, v.5, n.10, p.3471-84, 2007.
Poole K. Efflux-mediated multiresistance in Gram-negative bacteria. Clinical Microbiology and Infection, v.1, n.10, p.2-26, 2004.
Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et la. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest, v.122, n.6, p.2115-21, 2002.
Rodrigues PMA, Carmo Neto E, Santos LRC, Knibel MF. Pneumonia associada à ventilação mecânica: epidemiologia e impacto na evolução clínica de pacientes em uma unidade de terapia intensiva. J. Bras. Pneumol., v.35, n.11, p.1084-1091, 2009.
https://dx.doi.org/10.1590/S1806-37132009001100005
Sales VM, Oliveira E, Célia R, Gonçalves FR, Melo CC. Análise microbiológica de superfícies inanimadas de uma Unidade de Terapia Intensiva e a segurança do paciente. Re-vista de Enfermagem Referência, v.4, n.3, p.45-53, 2014.
Silva RNP. A Importância do Acinetobacter baumannii na infecção adquirida nos cuidados de saúde. 2009. 21p. Dis-sertação (Mestrado Integrado em Medicina) - Universidade do Porto, Porto.
Torres H et al. Acinetobacter baumanii multirresistente: situa-ción clínica actual y nuevas perspectivas. Revista Espanhola de Quimioterapia, v.23, n.1, p.12-19, 2010.
Uc-Cachón AH et al. High Prevalence of Antimicrobial Re-sistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico. Medicina, v.55, n. 588, p. 1-13, 2019. https://doi:10.3390/medicina5509058
Verma, P; Tiwari, Vishvanath. Targeting Outer Membrane Protein Component AdeC for the Discovery of Efflux Pump Inhibitor against AdeABC Efflux Pump of Multidrug Re-sistant Acinetobacter baumannii. Cell Biochem Biophys, v.76, n.3, p.391-400, 2018. https://doi:10.1007/s12013-018-0846-5
Zarrilli R et al. Molecular epidemiology of sequential out-breaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Mi-crobiol., v.42, n.3, p.946-53, 2004.
Zimbler DL. et al. Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii. Biometals, v.22, n.1, p.23–32, 2009.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 - Journal of Biotechnology and Biodiversity
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY 4.0 at http://creativecommons.org/licenses/by/4.0/) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (Available at The Effect of Open Access, at http://opcit.eprints.org/oacitation-biblio.html).
